PT Merck Tbk (ISX:MERK) Cyclically Adjusted FCF per Share: Rp254.12 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MERK PT Merck Tbk ISX:MERK
87 GF Score
Price Rp3,930.00
GF Value Rp4,989.21
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Merck Tbk Cyclically Adjusted FCF per Share?

PT Merck Tbk ISX:MERK +3.42% 87 Cyclically Adjusted FCF per Share is Rp254.12 as of Jun. 2026. GuruFocus rates ISX:MERK with a GF Score™ of 87/100 and a GF Value™ of Rp4,989.21 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

PT Merck Tbk's adjusted free cash flow per share for the three months ended in Jun. 2026 was Rp26.130. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is Rp254.12 for the trailing ten years ended in Jun. 2026.

During the past 12 months, PT Merck Tbk's average Cyclically Adjusted FCF Growth Rate was -100.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of PT Merck Tbk was 1.90% per year. The lowest was -13.60% per year. And the median was -1.70% per year.

As of today (2026-08-04), PT Merck Tbk's current stock price is Rp3930.00. PT Merck Tbk's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was Rp254.12. PT Merck Tbk's Cyclically Adjusted Price-to-FCF of today is 15.47.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of PT Merck Tbk was 34.20. The lowest was 6.86. And the median was 19.00.


PT Merck Tbk  (ISX:MERK) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

PT Merck Tbk's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=3930.00/254.12
=15.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of PT Merck Tbk was 34.20. The lowest was 6.86. And the median was 19.00.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


PT Merck Tbk Cyclically Adjusted FCF per Share Related Terms


PT Merck Tbk Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for PT Merck Tbk's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Merck Tbk Cyclically Adjusted FCF per Share Chart

PT Merck Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 180.52 185.84 193.85 141.34 196.47

PT Merck Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.29 163.23 196.47 221.96 254.12

ISX:MERK vs ZTS, UTHR, VTRS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Merck Tbk's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Merck Tbk Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Merck Tbk's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where PT Merck Tbk's Cyclically Adjusted Price-to-FCF falls into.


ISX:MERK
87GF Score
PT Merck Tbk ISX:MERK
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Merck Tbk Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Merck Tbk's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=26.13/137.6954*137.6954
=26.130

Current CPI (Jun. 2026) = 137.6954.

PT Merck Tbk Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 141.094 104.142 186.552
201612 148.819 105.222 194.747
201703 -175.403 106.476 -226.832
201706 158.761 107.722 202.937
201709 41.247 108.020 52.578
201712 119.103 109.017 150.435
201803 9.255 110.097 11.575
201806 360.144 111.085 446.418
201809 -104.708 111.135 -129.733
201812 59.198 112.430 72.501
201903 -74.361 112.829 -90.750
201906 -636.010 114.730 -763.318
201909 -0.824 114.905 -0.987
201912 173.819 115.486 207.247
202003 -69.313 116.252 -82.098
202006 -67.494 116.630 -79.685
202009 97.811 116.397 115.709
202012 129.529 117.318 152.027
202103 99.743 117.840 116.549
202106 124.478 118.184 145.029
202109 119.171 118.262 138.754
202112 -60.529 119.516 -69.736
202203 97.710 120.948 111.240
202206 -1.196 123.322 -1.335
202209 -43.211 125.298 -47.486
202212 147.899 126.098 161.502
202303 129.089 126.953 140.013
202306 78.909 127.663 85.110
202309 97.516 128.151 104.778
202312 105.139 129.395 111.884
202403 10.969 130.607 11.564
202406 46.585 130.792 49.044
202409 -7.887 130.361 -8.331
202412 37.118 131.432 38.887
202503 48.330 131.948 50.435
202506 297.500 133.241 307.447
202509 25.435 133.819 26.172
202512 433.748 135.271 441.522
202603 181.218 136.539 182.753
202606 26.130 137.695 26.130

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of Rp254.12 mean?
PT Merck Tbk (ISX:MERK) has a Cyclically Adjusted FCF per Share of Rp254.12 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on PT Merck Tbk and its competitors.
Is PT Merck Tbk's Cyclically Adjusted FCF per Share too high?
PT Merck Tbk's current Cyclically Adjusted FCF per Share is Rp254.12. Overall, PT Merck Tbk has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Merck Tbk's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
PT Merck Tbk's Cyclically Adjusted FCF per Share of Rp254.12 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on PT Merck Tbk and its competitors. PT Merck Tbk's current Cyclically Adjusted FCF per Share is Rp254.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Merck Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Merck Tbk (ISX:MERK) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp4,989.21, compared to a current price of Rp3,930.00 — trading 21.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is Rp254.12. PT Merck Tbk's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For PT Merck Tbk (ISX:MERK), the current Cyclically Adjusted FCF per Share is Rp254.12 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Merck Tbk (ISX:MERK) Overvalued in 2026?

Based on GuruFocus' analysis, PT Merck Tbk stock appears to be undervalued. The current stock price of Rp3,930.00 is trading 21.2% below its estimated GF Value™ of Rp4,989.21. GuruFocus considers PT Merck Tbk to be Modestly Undervalued.

Key valuation signals for ISX:MERK:

  • Cyclically Adjusted FCF per Share: Rp254.12
  • GF Value™: Rp4,989.21 vs. price of Rp3,930.00 (21.2% below fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the ISX:MERK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Merck Tbk Business Description

Address Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines for colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, as well as thyroid disorders such as hypothyroidism.
87GF Score

Get the complete analysis for ISX:MERK

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp3,930.00
Price
Rp4,989.21
GF Value